Eight patients with inflammatory myofibroblastic tumor treated with rigid bronchoscopy.

ABSTRACT:

Background

Pulmonary inflammatory myofibroblastic tumor (IMT) accounts for 0.04-0.7% of all lung tumors, and endobronchial IMT accounts for only 10% of all pulmonary IMTs. Little is known about the therapeutic outcomes of rigid bronchoscopy for endobronchial IMT. Here, we report a case series of eight patients with endobronchial IMT underwent rigid bronchoscopy.

Methods

We retrospectively analyzed eight patients with endobronchial IMT between January 2004 and December 2023.

Results

The median age of our patients was 36 years, and 62.5% were male. Dyspnea was the predominant symptom in cases where the tumor was centrally located (n = 6), whereas hemoptysis was the predominant symptom in peripherally located tumors (n = 2). Most cases had high contrast enhancement and a

SUBMITTER: Jeong BH 

PROVIDER: S-EPMC11759437 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature